Sort by
Keyphrases
HIV-positive
100%
Cancer Prevention
100%
Anal Cancer
100%
Men Who Have Sex with Men
100%
High-grade Squamous Intraepithelial Lesion
100%
Adjuvant HPV Vaccination
100%
Human Papillomavirus Vaccine
83%
Quadrivalent
83%
Vaccination
50%
Cost-effectiveness
50%
HIV-infected MSM
50%
Expected Value of Perfect Information
50%
Incremental Cost-effectiveness Ratio
33%
Expected Value of Partial Perfect Information
33%
Vaccine Effectiveness
16%
High Risk
16%
Management Strategy
16%
High-risk Individuals
16%
Clinical Research
16%
New Evidence
16%
Population Level
16%
Management Approach
16%
Cancer Burden
16%
Treatment Efficacy
16%
Willingness-to-pay Threshold
16%
Treatment Compliance
16%
Estimated Cost
16%
Quadrivalent Human Papillomavirus Vaccine
16%
Cohort Model
16%
Markov State Transition
16%
Value of Information Analysis
16%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Wart Virus
100%
Cancer Prevention
100%
Cost-Effectiveness Analysis
100%
Anal Cancer
100%
Men Who Have Sex with Men
100%
Adjuvant Therapy
80%
Health Care Cost
60%
Quality Adjusted Life Year
40%
Recurrent Disease
20%
Clinical Research
20%
Wart Virus Vaccine
20%
Precursor
20%
Patient Compliance
20%